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ABSTRACT
Purpose: RENEB, ‘Realising the European Network of Biodosimetry and Physical Retrospective
Dosimetry,’ is a network for research and emergency response mutual assistance in biodosimetry within
the EU. Within this extremely active network, a number of new dosimetry methods have recently been
proposed or developed. There is a requirement to test and/or validate these candidate techniques and
inter-comparison exercises are a well-established method for such validation.
Materials and methods: The authors present details of inter-comparisons of four such new methods:
dicentric chromosome analysis including telomere and centromere staining; the gene expression assay
carried out in whole blood; Raman spectroscopy on blood lymphocytes, and detection of radiation-
induced thermoluminescent signals in glass screens taken from mobile phones.
Results: In general the results show good agreement between the laboratories and methods within the
expected levels of uncertainty, and thus demonstrate that there is a lot of potential for each of the can-
didate techniques.
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Conclusions: Further work is required before the new methods can be included within the suite of reliable
dosimetry methods for use by RENEB partners and others in routine and emergency response scenarios.
Introduction
Biological and physical retrospective dosimetry is a recog-
nised technique to assist in triage of suspected exposed indi-
viduals following an accidental or deliberate radiation
exposure involving potentially large numbers of casualties.
The state of the art in terms of biodosimetry techniques is
represented by the achievements of the EU FP7-funded
‘Realising the European Network of Biodosimetry and Physical
Retrospective Dosimetry’ (RENEB) project. Development dur-
ing the project focused on establishing a working network for
biological and physical dosimetry emergency preparedness
and response within the EU (Kulka et al. 2015, 2016). While
the funded part of the RENEB project came to a close at the
end of 2015, RENEB remains an active network bringing
together members from 23 institutions from 16 EU countries
with expertise in preparedness and management of radio-
logical or nuclear incidents, biological and physical methods
of retrospective dosimetry analysis, and many other related
competencies. Furthermore, many members of the biological
and physical retrospective dosimetry communities are also
active in the European Radiation Dosimetry Group (EURADOS)
Working Group 10 (R€uhm et al. 2016).
Within the fields of biological and physical retrospective
dosimetry, there are a number of established techniques
including the dicentric chromosome aberration assay, prema-
ture chromosome condensation (PCC), the micronucleus assay
(MN), the fluorescence in situ hybridisation translocation assay
(FISH), gene expression (GE), assessment of gamma-H2AX sig-
nals, electron paramagnetic resonance spectroscopy (EPR)
and optically stimulated luminescence (OSL) techniques
(Kulka et al. 2015, 2016; International Atomic Energy Agency
[IAEA] 2011). However, EURADOS and RENEB network mem-
bers represent many active university departments and
national government and public radiation research institutes
and further collaborate with many partners worldwide, for
instance through IAEA and WHO initiatives (Maznyk et al.
2012; IAEA 2011). As such, new developments within this field
which could be exploited for biodosimetry are a constant
occurrence. One of the key outputs of RENEB was a quality
manual which outlines a framework for quality assurance and
quality management within the operational network (Gregoire
et al. 2016). When a new dosimetry technique is proposed, it
is necessary to develop, test and then validate the method
before it can be said to reach a sufficient standard for inclu-
sion as a fully operational dosimetry method. Inter-compari-
son exercises are a recognised method for validating tools
and techniques within the field of biological and physical
retrospective dosimetry (Badie et al. 2013; Romm et al. 2013;
Ainsbury et al. 2014; Abend et al. 2016).
The authors here present the results of a recent inter-com-
parison involving three new techniques for biological and
physical retrospective dosimetry: the gene expression assay
carried out in whole blood (GE), Raman spectroscopy on
blood lymphocytes (RS), and detection of radiation-induced
thermoluminescence signals in glass displays taken from
smart phones (TL). In addition, three well established and two
relatively new laboratories to the RENEB consortium carried
out the ‘gold standard’ dicentric chromosome aberration
assay (DCA) as the reference technique for comparison with
the results of the new assays. Moreover we performed an
inter-comparison with a new approach for the detection of
dicentric chromosomes by the introduction of telomere and
centromere (TC) staining. This approach allows for better scor-
ing of dicentrics in metaphases improving the dose response
relationship (M’kacher et al. 2014). The resulting curve is more
reliable and robust than those based on the classical dicentric
assay considered to be the gold standard in the field of the
biodosimetry.
The organisation of the inter-comparison and the materi-
als, methods and results for the DCA and RS assays are here
presented in detail; the results of the GE and TL assays are
given only in brief with the detailed materials, methods and
results presented in two additional papers (GE: Manning et al.
2016; TL: Woda et al. in preparation).
Materials and methods
Inter-comparison partners
For the DCA, five laboratories took part in the exercise: PHE,
BfS, IRSN, IRBA and RSC (NB: See the author list for definitions
of the participant acronyms). For DCA detected with telomere
and centromere probes (DCA-TC), 17 laboratories took part in
the exercise: BFS, UULM, CEA, ENEA, ICHTJ, INSP, IRSN, IST/ITN,
LAFE, NCRRP, NCSRD, NRIRR, PHE, SERMAS, UAB, UNITUS, US.
For the GE assay, five laboratories participated: PHE, BIR,
INCT, SCK-CEN and FzJ. One laboratory, DIT, carried out RS. A
total of 11 laboratories – four RENEB partners (IRSN, ISS,
HMGU, PHE) and seven EURADOS partners (SURO, DUR, LU,
SCK-CEN, UNIMI, OSU, KAERI) – took part in the TL inter-com-
parison. Thus a total of 30 partners participated in the exer-
cises as a whole.
Sampling, irradiation and distribution
For the biological assays DCA, GE and RS, blood samples
were taken by venipuncture at PHE from four healthy volun-
teers with informed consent in accordance with local ethics
procedures (Berkshire REC 09/H0505/87). Whole blood was
irradiated using the Medical Research Council Co-60 gamma
irradiation facility (Harwell Campus, Didcot, Oxfordshire, UK),
with a horizontal geometry, at an acute dose rate of
0.7 Gy min1. The irradiation system is calibrated and trace-
able to national standards, to give dose to water within a
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Perspex block holding the 10ml blood tubes and all doses
were delivered to within an accuracy of 5%. Irradiation took
place at room temperature but samples were kept at 37 C
prior to irradiation and for 2 h for DCA and RS and 24 h for
GE following irradiation.
For DCA-TC, the analysis was performed on images sent to
the participants from slides prepared during the first RENEB
dicentric intercomparison exercise (Oestreicher et al. 2016)
with doses of 0, 0.94 and 3.27Gy simulated whole body
exposure and a dose of 4.75 Gy simulated to 50% of the body
(mixed 1:1 with unirradiated blood from the same donor).
Telomeres and centromeres were stained using the Q-FISH
technique with a Cy-3-labelled PNA probe specific for
TTAGGG for telomeres and a FITC-labeled PNA probe specific
for centromere sequences (both from Panagene, Daejon,
South Korea), as described in detail in M’kacher et al. (2014).
Images of metaphase cells were acquired using automated
acquisition module Autocapt software (MetaSystems, version
3.9.1). Image galleries were sent to each partner involved in
the inter-comparison.
For RS and GE, it was first necessary to create calibration
curves, thus samples were irradiated to doses of 0, 0.16, 0.41,
0.70, 1.43, 2.92 Gy and shipped to the partners in order for
calibration curves to be created within each laboratory.
Following establishment of the GE and RS calibration curves,
four blind samples of at least 2ml each were shipped to each
partner for the DCA, RS or GE assays in December 2015. The
doses given were 0, 0.44, 1.08 and 1.89 Gy.
In all cases, the samples were packed according to IATA
packaging instructions 650 applied to UN 3373 Biological
Substance Category B and shipping followed PHE’s standard
operating procedures. Shipment occurred at ambient tem-
perature for the DCA and RS samples; the blood for GE was
shipped frozen on dry ice. Each package of DCA and RS sam-
ples also contained a temperature logger, which revealed
that during shipment the DCA and RS samples remained
below 20 C at all times. The majority of partners received the
samples within 24 h of posting, but the partner carrying out
RS received the sample after 45 h.
For TL on glass, training on sample preparation and meas-
urement protocol was carried out at HMGU in November
2015. All RENEB partners and three EURADOS WG 10 mem-
bers attended. Intact mobile phone samples were irradiated
at IRSN using a 4MV linear accelerator, with irradiation taking
place in air kerma conditions and with the screen facing
towards the source. Three samples were irradiated per partici-
pating laboratory, the nominal doses being 0.6, 1.5 and
2.5 Gy. Full details will appear in Woda et al. (in preparation).
Analysis and reporting of results
Dicentric assay
Upon receipt, each partner processed the samples and scored
aberrations according to their own standard operating proce-
dures with minor variations between the laboratories, but all
according to the recommendations of the IAEA (2011) and
refined during the MULTIBIODOSE project (Romm et al. 2013)
and the two quality controlled exercises in the frame of
RENEB (Oestreicher et al. 2016). In brief, whole blood was
mixed with a suitable medium (either F10-Ham, RPMI, PB-Max
or MEM – various suppliers e.g. Fisher Scientific,
Loughborough, UK; Biochrom, Berlin, Germany; Life-
Technologies, Cergy Pontoise, France), supplemented as
required with 10–20% heat inactivated foetal calf serum, 1%
PHA (phytohaemagglutinin), 100 unitsml1 penicillin plus
100 lgml1 steptomycin and 2mM L-glutamine (all from
Fisher Scientific, Loughborough, UK). Cells were then cultured
for 48–50 h at 37 C with or without 5% CO2. The two labora-
tories using fluorescence plus Giemsa (FpG) staining added
5-bromodeoxyuridine (e.g. Sigma-Aldrich, Gillingham, UK;
Sigma, Steinheim, Germany; Sigma-Aldrich, France) at a con-
centration of 20–50 lMml1. Colcemid (e.g. Sigma-Aldrich,
Gillingham, UK; Roche, Mannheim, Germany; Sigma-Aldrich,
France) was added for 2–24 h at a concentration of 0.08–10
lg ml1 before termination of the cultures. Metaphases were
then harvested by a standard hypotonic treatment in 0.075 M
potassium chloride for 7–15min at 37 C followed by three
changes of 3:1 methanol:acetic acid fixative. Fixed cells were
dropped onto clean microscope slides, air dried and stained
with Giemsa (e.g. VWR International, Lutterworth, UK; Merck,
Darmstadt, Germany; Life-Technologies, Cergy Pontoise,
France), when cell cycle control was achieved with a long
Colcemid treatment, or the FpG technique to distinguish 1st
division cells.
The analysis was then performed in either manual mode
using a standard light microscope or using the automatic
scoring system Metafer 4 by MetaSystems (Altlussheim,
Germany). Following automated metaphase finding
(MSearch), cells were either scored manually or dicentric can-
didates were detected by the DCScore software from high
resolution images at 63 magnification (with oil, AutoCapt)
and then assessed by a scorer. Each participants’ own pre-
ferred classifier was used (Vaurijoux et al. 2009; Romm et al.
2013). Standardised scoring sheets were provided for both
manual and semi-automated scoring modes, and standard
scoring procedures were also applied. The only notable differ-
ence was that lab DCA_1, scored both dicentrics and centric
rings in manual mode, whereas all the other labs scored only
dicentrics. All labs scored only complete cells with exactly 46
centromeres in manual scoring mode but for semi-automatic
mode, scoring was carried out according to each labs’ chosen
classifier, according to standard practice (Romm et al. 2014).
For statistical analysis of the dicentric results, the variance to
mean ratio and u-test (the normalised unit of the standar-
dised normal distribution) were applied to test for departure
of the distribution of aberrations from Poisson and the Chi-
squared test was used to give an initial indication of the
homogeneity of scoring results between laboratories. To ana-
lyse the difference between the estimated doses with test
doses and the homogeneity of the dosimetry results between
laboratories, the z-test based on robust statistics was applied
according to ISO 13528, comparing applied test sample dose
to estimated dose within each dose group, separately for
manual and automated scoring. Finally, general linear model
analysis of variance (ANOVA) was applied to assess the
impact of the experimental variables of: scoring method
(semi-automatic vs. manual); dose and laboratory on the
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deviation of the test dose and actual dose for each measure-
ment. Post hoc testing (Tukey’s test and Dunnett’s test) was
applied to further investigate significant variables.
Dicentic assay with telomere and centromere staining
Each partner scored dicentrics, centric and acentric rings and
different types of acentric chromosomes. Acentrics with four
telomeres resulted from a fusion event generally accompany-
ing the formation of a dicentric or centric ring. Acentrics with
two telomeres were scored, representing terminal deletions
or unfused acentrics associated with a ring or dicentric as
well as acentrics without telomeres representing interstitial
deletions.
For a male donor, the centromere of chromosome Y had a
very weak signal and the DAPI image (strong heterochroma-
tin) was used to identify this chromosome.
The dose estimations were performed with the free soft-
ware CABAS V2.0 (Deperas et al. 2007). The dose effect curve
published in M’kacher et al. (2014) was used.
Raman spectroscopy
After receipt of the samples, peripheral blood mononuclear
cells (PBMC) were isolated. A total of 3ml of Dulbecco’s modi-
fied phosphate buffered saline (DPBS) (Sigma) was added to
3ml of blood, mixed by gentle inversion and overlaid over
3ml of Histopaque. Samples were then centrifuged at 400 g
for 30min at room temperature. The PBMC layer was
removed and washed three times. Finally, cells were centri-
fuged at 250 g for 5min at room temperature. The cell pellet
was then resuspended in 1ml of full media (RPMI þ12.5%
(v/v) FBS þ2mM L-glutamine (Sigma) supplemented with
2.5% (v/v) phytohaemagglutinin (PAA Laboratories). One ml
of cell suspension was transferred to a T25 flask containing
4ml of full media and incubated for 24 h at 37 C, 5% CO2 to
allow separation of lymphocytes and monocytes by plastic
adherence.
The cells were fixed using 2% paraformaldehyde in phos-
phate-buffered saline. From the suspension, 40 ll was drop
cast onto calcium fluoride (CaF2) slides. The slides were then
washed in deionised H2O and the samples were allowed to
dry before Raman spectroscopic measurements.
Raman spectroscopy was performed using a Horiba Jobin
Yvon Labram HR800 UV system, equipped with a 660 nm
solid-state diode laser delivering 100mW of power to the
sample. A spectrum of silicon, 1,4-Bis (2-methylstyryl) benzene
and NIST SRM 2245 were recorded for calibration purposes.
Multiple calibration spectra were recorded before recording a
sequential group of cellular spectra. Spectra were recorded
from 30–50 cells per sample. The cells were 8–12 lm in size
and each spectrum was recorded from individual cells using a
4 4 lm raster scan of the cell including both signal from its
nucleus and cytoplasm. Spectra were recorded with a 20-sec
integration time and averaged across three integrations per
spectrum. Spectra were recorded using a diffraction grating
ruled with 300 lines/mm giving a spectral resolution of
2.1 cm1. The confocal hole was set to 100 lm with the
grating centered at 1450 cm1. All spectra were recorded
within 1–2 weeks of slide preparation. Slides were stored in a
desiccator until measurement.
Raman spectral post processing and multivariate
statistical analysis
Spectra were imported into Matlab vR2015b (The Mathworks
Inc.) and were subjected to processing procedures detailed
elsewhere (Maguire et al. 2015), including wavenumber cor-
rection, vector normalization, removal of cosmic ray spikes
and background removal. First-order derivative spectra were
also taken using a Savitzky-Golay derivative (with a 7-point
window fitting a 5th order smoothing function) prior to
analysis.
Multivariate statistical analysis was conducted using the R
statistical software package (http://www.r-project.org) and
using sparse Partial Least Squares Regression (SPLSR) within
the caret package (Kuhn 2008).
GE and TL
For the GE assay, five established gene expression
laboratories each used their own specific platforms for ana-
lysis. The materials and methods are described in Manning
et al. (2016).
TL measurements were carried out following the protocol
described in Discher and Woda (2013) and Discher et al.
(2013), using a single dose calibration point at 1 Gy.
Each participant prepared one glass aliquot and, if feasible, a
second one that was additionally treated with HF (Discher
et al. 2013). Full details of the materials and methods for the
TL assay will appear in Woda et al. (in preparation).
Results
Dicentric assay
Of the five participating laboratories, two laboratories carried
out only automated analysis and three laboratories carried
out both manual and automated analysis. The curves used by
the five participating laboratories are illustrated in Figure 1.
Four laboratories used their own calibration curves and one
laboratory, lab DCA_1, used calibration curves from the litera-
ture (IAEA [2011] for the manual curve DCA_1_m and
Vaurijoux et al. [2015] for the automated curve DCA_1_a). The
calibration curves were all created using either Cs-137 or Co-
60 gamma irradiation with acute dose rates ranging from
0.27–0.5 Gy min1 and irradiation at 37 C or room tempera-
ture. As expected, Figure 1 shows differences in the calibra-
tion responses between the scoring modes, but good
agreement between the laboratories within the automated
(_a) or manual (_m) scoring modes.
The scoring and dosimetry results for the dicentric
chromosome aberration assay are given in Table 1.
The u-test statistic and variance to mean ratio results indi-
cate departure from Poisson for six of the reported results –
given in bold in Table 1.
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The Chi-squared test revealed no evidence of any depart-
ure from homogeneity of scoring within any of the dose
groups (Chi p all >0.89). The robust z-test results are given in
Table 2. The data presented demonstrate a highly satisfactory
set of results – with only two dose estimates out of the thirty
two results (5 labs in automated mode 4 samples, plus 3
labs in manual mode 4 samples) being significantly different
from the actual dose according to the robust z-test. Figure 2
illustrates the cell scored by lab DCA_4 as containing 1 dicen-
tric and 1 tricentric.
Table 1. Dicentric scoring results for the blind test dose samples from the participating laboratories.
Dicentric distribution
Scoring method Test dose (Gy) Lab Cells Dics CR y SEy 0 1 2 3 4 d SEd u
Automated 0.44 DCA_1 3449 46 – 0.013 0.002 3403 46 0 0 0 0.99 0.02 0.55
DCA_2 4613 71 – 0.015 0.002 4544 67 2 0 0 1.04 0.02 1.99
DCA_3 3745 43 – 0.011 0.002 3702 43 0 0 0 0.99 0.02 0.49
DCA_4 2076 24 – 0.012 0.002 2052 24 0 0 0 0.99 0.03 0.37
DCA_5 1839 14 – 0.008 0.002 1825 14 0 0 0 0.99 0.03 0.22
1.08 DCA_1 3143 211 – 0.067 0.005 2935 205 3 0 0 0.96 0.03 1.53
DCA_2 3660 179 – 0.049 0.004 3490 163 6 0 1 1.09 0.02 3.67
DCA_3 3662 174 – 0.048 0.004 3498 154 10 0 0 1.07 0.02 2.91
DCA_4 2101 109 – 0.052 0.005 1999 96 5 1 0 1.10 0.03 3.11
DCA_5 2183 77 – 0.064 0.007 2109 71 3 0 0 1.04 0.03 1.43
1.89 DCA_1 3006 344 – 0.114 0.006 2676 316 14 0 0 0.97 0.03 1.27
DCA_2 3619 552 – 0.153 0.006 3103 481 34 1 0 0.98 0.02 0.78
DCA_3 3099 260 – 0.084 0.005 2854 231 13 1 0 1.04 0.03 1.56
DCA_4 2624 323 – 0.123 0.007 2322 282 19 1 0 1.01 0.03 0.49
DCA_5 1586 143 – 0.090 0.008 1449 131 6 0 0 0.99 0.04 0.16
0 DCA_1 3021 4 – 0.001 0.001 3017 4 0 0 0 1.00 0.02 0.05
DCA_2 3374 1 – 0.000 0.000 3373 1 0 0 0 1.00 0.00 0.00
DCA_3 3420 10 – 0.003 0.001 3411 8 1 0 0 1.20 0.02 8.60
DCA_4 1567 7 – 0.004 0.002 1562 4 0 1 0 1.85 0.03 25.80
DCA_5 2862 5 – 0.002 0.001 2857 5 0 0 0 1.00 0.02 0.06
Manual 0.44 DCA_1 500 14 0 0.028 0.007 486 14 0 0 0 0.97 0.06 0.43
DCA_4 500 14 0 0.028 0.007 486 14 0 0 0 0.97 0.06 0.43
DCA_5 500 10 0 0.020 0.006 490 10 0 0 0 0.98 0.06 0.30
1.08 DCA_1 500 81 0 0.162 0.016 421 77 2 0 0 0.89 0.06 1.76
DCA_4 500 60 2 0.120 0.015 444 52 4 0 0 1.02 0.06 0.25
DCA_5 500 46 2 0.092 0.014 457 40 3 0 0 1.04 0.06 0.65
1.89 DCA_1 500 153 0 0.306 0.021 363 121 16 0 0 0.91 0.06 1.51
DCA_4 500 138 15 0.276 0.023 380 103 16 1 0 1.00 0.06 0.02
DCA_5 500 114 4 0.228 0.021 400 88 10 2 0 1.05 0.06 0.87
0 DCA_1 500 1 0 0.002 0.002 499 1 0 0 0 1.00 0.00 0.00
DCA_4 500 0 0 0.000 0.000 500 0 0 0 0 1.00 0.00 0.00
DCA_5 500 2 0 0.004 0.003 498 2 0 0 0 1.00 0.05 0.05
Dics: dicentrics; CR: centric rings; y: yield of aberrations per cell; SEy: standard error on y; d: dispersion coefficient, the variance to mean ratio (which should be 1
for the Poisson distribution); SEd: standard error on d; u: u-test statistic (with a value between 1.96 and þ1.96 indicating no departure from Poisson).
Figure 1. Calibration curves used by the five laboratories participating in the DCA assay: DCA_1 to DCA_5 in either manual (_m – solid lines) or automated (_a –
dashed lines) scoring modes.
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In addition to the formal z-test, ANOVA was applied to
assess the impact of the experimental variables of: scoring
method (semi-automatic vs. manual); dose and laboratory on
the variation between the test dose and actual dose for each
measurement. As expected, dose was highly significant
(p< 0.001) and there was no evidence of a difference
between the automatic and manual data (p¼ 0.834). There
was a significant effect of laboratory (p¼ 0.002) however
post-hoc testing revealed that this discrepancy was due to
laboratory DCA_1, as evidenced by Dunnett’s test for com-
parison of the laboratory 1 results with the results from the
other labs (p DCA_1 vs. DCA_2: 0.002; p DCA_1 vs. DCA_3:
0.032; p DCA_1 vs. DCA_4: 0.005; p DCA_1 vs. DCA_5: 0.008;
All other pairwise comparison p values >0.70) and Figure 3.
Dicentic assay with telomere and centromere staining
Figure 4 illustrates the scoring methodology for the DCA-TC
method. In total results from 17 labs were available however
in one lab galleries were scored by two scientists and in two
labs, galleries were scored by three scientists. Thus the inter-
comparison was performed on 22 sets of data.
The DCA-TC scoring method provided highly homoge-
neous results: With each reported dose being within 20%
of the actual dose for both the whole body exposure
samples (0.94 Gy and 3.27 Gy). Each partner correctly iden-
tified the zero dose point and each partner also identified
the simulated partial body irradiation with a mean esti-
mate of 67 ± 4%. The results for 3.27Gy are shown in
Figure 5.
Raman spectroscopy
A model was trained using all of the Raman spectra from the
training samples (with doses of 0, 0.25, 0.5, 1, 2, 3 and 4Gy),
and optimized for complexity using ten-fold cross-validation
within the training set. A dose prediction was then generated
for each unseen test spectrum by passing it through the
model. The mean dose prediction plus its standard deviation
were then calculated as:
 Test dose: 0.44 Gy; dose estimate: 0.65 ± 0.19 Gy;
 Test dose: 1.08 Gy; dose estimate: 0.93 ± 0.45 Gy;
 Test dose: 1.89 Gy; dose estimate: 0.73 ± 0.21 Gy;
 Test dose: 0 Gy; dose estimate: 0.13 ± 0.41Gy.
GE and TL
Additional data and fully detailed results for the GE assay will
appear in Manning et al. (2016) and for the TL assay will
appear in Woda et al. (in preparation). In brief, the GE results
are given in Table 3, which is reproduced from Manning et al.
(2016).
For the TL measurements, we here report that the majority
of measured doses agree with the nominal dose for all three
dose categories within the 95% confidence interval. No sig-
nificant dose underestimation was observed, implying that
the tested measurement protocol successfully corrected for
signal fading and optical bleaching due to mobile phone use.
Table 2. Dose estimation results for the blind test dose samples from the par-
ticipating laboratories.
Whole body dose
estimate Robust statistics
Scoring
method
Test
dose (Gy) Lab Dose (Gy) LCL UCL z score z result
Automated 0.44 DCA_1 0.62 0.478 0.753 1.134 Satisfactory
DCA_2 0.68 0.57 0.79 1.519 Satisfactory
DCA_3 0.46 0.24 0.73 0.129 Satisfactory
DCA_4 0.33 0.17 0.48 0.722 Satisfactory
DCA_5 0.49 0.30 0.67 0.290 Satisfactory
1.08 DCA_1 1.60 1 1.767 2.130 Questionable
DCA_2 1.41 1.29 1.54 1.369 Satisfactory
DCA_3 1.29 1.01 1.61 0.869 Satisfactory
DCA_4 1.06 0.87 1.26 0.079 Satisfactory
DCA_5 1.14 0.92 1.37 0.252 Satisfactory
1.89 DCA_1 2.13 1.934 2.331 0.366 Satisfactory
DCA_2 2.71 2.54 2.89 1.750 Satisfactory
DCA_3 1.83 1.52 2.20 0.359 Satisfactory
DCA_4 1.89 1.67 2.12 0.206 Satisfactory
DCA_5 1.87 1.55 2.18 0.268 Satisfactory
0 DCA_1 0.06 0 0.232 0.828 Satisfactory
DCA_2 0.00 0.00 0.09 0.000 Satisfactory
DCA_3 0.10 0.00 0.35 1.315 Satisfactory
DCA_4 0.14 0.00 0.28 1.788 Satisfactory
DCA_5 0.17 0.00 0.35 2.288 Questionable
Manual 0.44 DCA_1 0.505 0.33 0.68 0.773 Satisfactory
DCA_4 0.57 0.38 0.76 1.545 Satisfactory
DCA_5 0.42 0.26 0.58 0.214 Satisfactory
1.08 DCA_1 1.438 1.256 1.62 1.432 Satisfactory
DCA_4 1.14 1.11 1.54 0.232 Satisfactory
DCA_5 1.01 0.85 1.16 0.288 Satisfactory
1.89 DCA_1 2.038 1.85 2.22 0.510 Satisfactory
DCA_4 2.12 1.90 2.34 0.783 Satisfactory
DCA_5 1.64 1.49 1.79 0.862 Satisfactory
0 DCA_1 0.031 0.00 0.197 0.369 Satisfactory
DCA_4 0.00 0.00 0.02 0.000 Satisfactory
DCA_5 0.14 0.00 0.30 1.678 Satisfactory
LCL: lower 95% confidence limit; UCL: upper 95% confidence limit; z-score is
calculated using the robust standard deviation according to Algorithm A of ISO
13528 (2008) and z result is based on the classification system of satisfactory
scores for z <¼ 2; questionable scores for 2 < z <¼3 and unsatisfactory
scores for z > 3.
Figure 2. A cell from a control, 0 Gy, exposed sample identified by the DCScore
software (automated scoring mode) as having three dicentrics; subsequently
checked by eye and confirmed as containing 1 tricentric and 2 dicentrics
(circled) – one of which was ignored according to the automated scoring proto-
col of laboratory DCA_4.
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Discussion and conclusions
Biological and physical retrospective methods of dose assess-
ment are highly useful methods to assist medical personnel
in triage of exposed or suspected exposed individuals follow-
ing a radiation accident or incident. The newly renamed
Running the European Network of Biological Dosimetry and
Physical Retrospective Dosimetry (RENEB) network represents
the state of the art in terms of emergency readiness.
However, the field of radiation biomarkers is quickly develop-
ing, so in order to maintain the status quo, newly developed
methods must be assessed and integrated into the RENEB
‘toolkit’ as appropriate.
The aims of this inter-comparison were:
 To test the performance of DCA-TC labelling in an inter-
comparison exercise;
 To test performance of the new method of GE on whole
blood against the benchmark of the dicentric assay in a
quality controlled dosimetry exercise;
 To test performance of the new method of TL on glass;
 To evaluate performance of the completely new technique
of RS in a blind inter-comparison exercise.
The dicentric assay is still recognised as the international
gold standard method for biological dose assessment
(Oestreicher et al. 2016), and as such is well placed to act as
the validation standard in this inter-comparison. Detailed ana-
lysis of the results is also justified. The u-test statistic and vari-
ance to mean ratio results indicate departure from Poisson
for six of the reported results – given in bold in Table 1. In
this exercise, all the samples simulated whole body irradi-
ation, and as such this result is somewhat unexpected. It is
notable that the overdispersed results all come from auto-
mated analyses. The fact that lab DCA_4 observed one cell
with 1 tricentric and 2 dicentric (Figure 2) for the control sam-
ple is somewhat unexpected: in automated mode (DCScore) 1
dicentric and 1 tricentric chromosome was detected
(recorded in Table 1 as 3 dicentrics). Interestingly, Table 1
shows that lab DCA_3 also observed a multiaberrant cell,
with two dicentrics, in the control sample taken from the
sample individual. ‘Rogue cells’ are observed in both exposed
and unexposed populations and there are several potential
causes (Rozgaj et al. 2002, M’kacher et al. 2010; Druzhinin
et al. 2016). The history of this volunteer was reassessed in
response to this observation but no recent radiation expo-
sures (X-ray, CT or otherwise) or other potential contributing
factors were identified. However, the probability of observing
Figure 3. Tukey’s simultaneous 95% confidence limits on the absolute differences between the true dose and the mean dose. If an interval does not contain zero, the
corresponding means are significantly different.
Figure 4. Detection of unstable chromosome aberrations after telomere (red;
fluorescence staining at the ends of the chromosomes) and centromere (green;
fluorescence staining at the centre of the chromosomes) staining. A dicentric
chromosome corresponds to two green centromere signals and four red telo-
mere signals at the ends of the chromosome. A chromosome ring corresponds to
a circular chromosome with a green centromere signal and without red telomere
signals. An acentric chromosome corresponds to a chromosome fragment with-
out a green centromere signal with or without red telomere signals.
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seven dicentrics in total in 1567 cells given the Poisson distri-
bution is around 1.4%, so it is possible that this observation
was simply due to chance. Indeed, the larger number of cells
assessed in automated analyses naturally increases the
chance of observing total numbers of aberrations as well as
multiaberrant/rogue cells. Nevertheless, the observation of a
tricentric in an unexposed individual is unexpected and, in
this case, remains unexplained. Going forward, automatic
scoring of chromosomal aberrations, which facilitates collec-
tion of data from large numbers of cells, could be used to
progress knowledge in the prevalence of atypical cells
The Chi-squared test revealed no evidence of any depart-
ure from homogeneity of scoring within any of the dose
groups (Chi p all >0.89). However, as most laboratories used
their own calibration curves, the quantities of interest within
this part of the inter-comparison are the homogenetity of the
dose estimations and the variation between the dose esti-
mates and the true doses given to the test samples. The ISO
standard for proficiency testing through inter-laboratory com-
parisons 13528 (ISO 2005) recommends a number of methods
for comparing results from two or more laboratories. The
robust z-test has previously been usefully applied in bio-
dosimetry (Di Giorgio et al. 2011; Wilkins et al. 2015) and thus
is used again here. The results, which are presented in Table
2, demonstrate satisfactory agreement across the laboratories
for the vast majority of the data. This is further evidenced by
the ANOVA results, which show that only laboratory DCA_1
gave results significantly different from the mean. Of the two
‘questionable’ robust z-test results, one might be explained as
it comes from one of the newer RENEB members, who used a
calibration curve from the literature rather than their own
curve. It is thus recommended that this laboratory produce
their own manual and automatic calibration curves as soon
as possible and then participate in a further inter-laboratory
comparison to ensure that their results are homogeneous.
The second questionable result comes from a much more
experienced laboratory, so the result cannot be explained by
the need for further training or similar. However, the result
comes from one of the control samples, for which the
uncertainties are recognised to have the greatest impact.
Figure 5. Doses estimated using the DCA-TC method (Dicþ ring) from each of the partners compared to the physical dose of 3.27 Gy (red line). The error bars give
the Poisson standard error on the estimated dose.
Table 3. Reported dose estimates from laboratories running QRT-PCR or microarrays for each of the samples irradiated with a known (true) dose.
True dose for each sample (Gy) True dose for each sample (Gy)
0.0 0.4 1.1 1.9
MAD
(Gy)
No. of
measurements
out of ±0.5 Gy 0.0 0.4 1.1 1.9
MAD
(Gy)
No. of
measurements
out of ±0.5 Gy
Diluted blood Whole blood
approach: curve fit/gene(s) reported dose estimates (Gy) reported dose estimates (Gy)
Lab 1 FDXR 0.0 0.6 0.8 1.2 0.3 1 0.0 0.5 0.4 1.3 0.4 2
Lab 2 log FDXR 0.0 0.4 2.0 2.1 0.3 1 0.0 0.3 1.3 2.3 0.2 0
Lab 3 Hierarchical clustering 0.0 0.2 0.1 0 0.0 0.4 1.4 2.9 0.3 1
Regression analysis
6 (6) genes 0.0 0.8 2.5 2.4 0.6 1 0.0 0.8 1.4 2.1 0.2 0
4 (5) genes 0.0 0.7 2.5 2.3 0.5 1 0.0 0.5 1.3 2.0 0.1 0
2 (3) genes 0.0 0.5 2.3 2.4 0.4 1 0.0 0.5 1.2 1.9 0.1 0
K-nearest neighbour 0.0 0.5 2.0 2.0 0.3 1 0.0 1.0 1.0 2.0 0.2 1
Lab 4 Integrated over 12 (17) genes 0.0 0.6 1.5 2.4 0.3 0 0.0 0.7 2.0 2.8 0.5 2
Lab 5 Integrated over 8 genes 0.0 0.5 1.1 5.6 0.9 1 0.1 0.2 0.5 0.9 0.5 2
Mean 0.4 0.8 Mean 0.3 0.9
SEM 0.08 0.15 SEM 0.05 0.31
Numbers in bold refer to values used for descriptive statistics (mean and SEM calculations). Underlined numbers represent values lying outside the ±0.5 Gy uncer-
tainty interval. Reproduced from Manning et al. (2016). MAD: mean of the absolute differences.
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Further, the observed number of dicentrics was 5 in 2862
cells, which falls within the expected normal background of
0–2 in 1000 (IAEA 2011) and the reported lower 95% confi-
dence limit on the dose does encompass the true value of
0Gy. As such, this dose estimate can still be defined as
acceptable according to the IAEA (2011) and ISO 13528
(2005) guidelines. ANOVA further revealed that there was no
difference between the automated and manual results, again
demonstrating that the semi-automated methodology can
be applied for dosimetry purposes (e.g. Romm et al. 2013;
Vaurijoux et al. 2015). Indeed, Gruel and colleagues demon-
strated that semi-automated analysis can also be used in
emergency response, with dose estimates based on as few
as 50 cells (Gruel et al. 2013).
The dicentric assay is still recognised as the international
gold-standard method for biological dosimetry and classifica-
tion of genotoxic agents. The introduction of telomere and
centromere staining not only renders the scoring of dicentric
chromosomes and centric rings more reliable and robust but
also permits the detection of different types of acentric chro-
mosomes leading to the precise calculation of the number of
DNA double-strand breaks (DSB). Manual scoring following TC
staining in metaphase revealed a significantly higher fre-
quency of dicentrics (p< 103) (up to 30%) and estimated
DSB (p< 104) compared to uniform staining due to
improved detection of unstable chromosomal aberrations
leading to an improved dose response curve (M’Kacher et al.
2014).
The results of this intercomparison, illustrated in Figure 5
for the highest dose (3.27 Gy) whole body exposure sample,
where the greatest variation is thus expected, confirm the
accuracy of the DCA-TC methodology. However, it should be
noted that unlike the DCA assay, for the DCA-TC inter-com-
parison the labs scored the same images, so the positive
result is not unexpected. The next step for this assay will be
for laboratories to score slides they have made and stained
themselves and then to use their own calibration curve to
produce a dose estimate. Interestingly, telomere and centro-
mere staining can also be performed in non-stimulated lym-
phocytes following premature chromosome condensation in
which it permits dicentrics identification which is not possible
by conventional staining (M’Kacher et al. 2015). Further inter-
comparisons will also be needed to confirm the reproducibil-
ity of the scoring.
Raman spectroscopy is a validated technique for molecular
biochemical profiling which has recently been proposed as a
radiobiological dosimetry technique (Maguire et al. 2015). The
results of this inter-comparison show that the 0 and 1.08Gy
test samples corresponded to the dose estimates provided,
within the quoted standard deviations. The results for the
0.44Gy test sample were just outside the lower limit of the
resulting standard deviation, but inside the 95% confidence
limit, which can thus be counted as a successful comparison
according to ISO standard 13528 (2005). Indeed, for rapid cat-
egorization purposes, this result is satisfactory as it would
result in correct categorisation as a dose of <1Gy.
The remaining result, corresponding to the 1.89Gy test
sample, was given as 0.73 ± 0.21Gy. This is much lower than
the real dose and the confidence limits do not include the
true dose. It should be noted that the sparse PLS model
revealed that most of the variables within the spectra were
required for the optimisation of the regression (even using a
sparse model 475 from 632 variables were selected). This
suggests that most of the spectral features change with
dose, as seen previously (Meade et al. 2010, 2016; Maguire
et al. 2015). There was, however, much more spectral vari-
ability observed here than in previous studies. Raman spec-
troscopy is very sensitive to sample preparation and the
higher spectral variability may be due to the transport, cul-
ture and other experimental conditions. Thus, while the
lower dose result represent a success for Raman spectro-
scopic analysis as a biodosimeter, it is recommended that
further work is necessary to fully develop and validate the
methods for the full range of doses for which biodosimetry
is likely to be applied.
In addition to the established physical techniques of EPR
and OSL, TL on glass has recently been proposed as an add-
itional fortuitous dosimeter for radiation emergency response
(Discher et al. 2013). For TL in this inter-comparison, the
results are very encouraging, with the reported dose for all
three dose categories within the 95% confidence interval of
the test doses. No systematic difference in the quality of
results could be seen for laboratories that participated in the
training and laboratories that received detailed written
instructions on sample preparation and measurement only.
This is different to the results obtained for the inter-
comparison using OSL on surface mount resistors in mobile
phones, where misidentification of the right component was
the main source of error for untrained participants (Bassinet
et al. 2014; Trompier et al. 2016). In a few cases (four out of
30) a systematic overestimation of the given dose was
observed. The reason for this is currently not entirely clear,
preliminary results indicate the possibility of the existence of
a pronounced intrinsic, non-radiation induced signal. This will
be further investigated in Woda et al. (in preparation).
Transcriptional techniques are also fast becoming recog-
nised as being highly applicable to assessment of individual
radiation responses (Badie et al. 2013; Abend et al. 2016). For
GE, the full results will be reported in the parallel publication
(Manning et al. 2016); however, the main conclusions of this
exercise are that: irrespective of the analytical approach, com-
parable dose estimates of blinded samples were obtained by
all five laboratories and that the use of diluted or whole
blood does not affect dose estimations. Thus the use of
whole blood for identification of transcriptional biomarkers
can be further explored. It was also shown that an already
existing historical calibration curve can be used to provide
similar dose estimates.
It should also be noted that this exercise was designed as
an inter-comparison rather than a timed exercise, and as such
participants applying biological dosimetry analysis were asked
to evaluate doses using their chosen techniques to the best
of their ability over a timescale of several weeks, rather than
to use rapid analyses. For TL, the results were requested to
be returned to the coordinator within one week.
Overall, the DCA, DCA-TL, GE, TL and RS results were com-
parably reliable within the uncertainties associated with each
assay – however, for all the new assays there is more work to
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be done. The RENEB and EURADOS platforms are the obvious
choice for such development. The next stage for validation of
the new methods would be to run a timed exercise, in order
to ensure that the methods can be applied in ‘rapid categor-
ization’ so that they could produce useful information in a
mass casualty scenario, complementary to that already avail-
able from the existing RENEB tools.
Finally, it is recommended that a true biological and phys-
ical retrospective dosimetry inter-comparison exercise is car-
ried out within the next few years, in order to compare all
the working assays in a more realistic exposure scenario. Such
an exercise would require a great deal of planning, however
it would prove crucial to demonstrating the operational capa-
bilities of the platforms to respond during a large scale radi-
ation emergency.
Acknowledgements
The authors thank the wider members of the RENEB consortium and the
Advisory Board members for their support of this work and M. Di Giorgio
for the use of the spreadsheet for calculating robust statistics.
Disclosure statement
The authors report no conflicts of interest. The authors alone are
response for the content and writing of the paper.
Funding
This work was supported by the EU within the 7th Framework
Programme [RENEB project, grant agreement No. 295513] and partly sup-
ported by the European Radiation Dosimetry Group [EURADOS; WG10].
References
Abend M, Badie C, Quintens R, Kriehuber R, Manning G, Macaeva E,
Njima M, Oskamp D, Strunz S, Moertl S, et al. 2016. Examining radi-
ation-induced in vivo and in vitro gene expression changes of the per-
ipheral blood in different laboratories for biodosimetry purposes: first
RENEB gene expression study. Radiat Res. 185:109–123.
Ainsbury EA, Al-Hafidh J, Bajinskis A, Barnard S, Barquinero JF, Beinke C,
de Gelder V, Gregoire E, Jaworska A, Lindholm C, et al. 2014. Inter-
and intra-laboratory comparison of a multibiodosimetric approach to
triage in a simulated, large scale radiation emergency. Int J Radiat Biol.
90:193–202.
Badie C, Kabacik S, Balagurunathan Y, Bernard N, Brengues M, Faggioni G,
Greither R, Lista F, Peinnequin A, Poyot T, et al. 2013. Laboratory inter-
comparison of gene expression assays. Radiat Res. 180:138–148.
Bassinet C, Woda C, Bortolin E, Della Monaca S, Fattibene P, Quattrini MC,
Bulanek B, Ekendahl D, Burbidge CI, Cauwels V, et al. 2014.
Retrospective radiation dosimetry using OSL of electronic components:
results of an inter-laboratory comparison. Radiat Measure. 71:475–479.
Deperas J, Szluinska M, Deperas-Kaminska M, Edwards A, Lloyd D,
Lindholm C, Romm H, Roy L, Moss R, Morand J, et al. 2007. CABAS: a
freely available PC program for fitting calibration curves in chromo-
some aberration dosimetry. Radiat Protect Dosim. 124:115–123.
Di Giorgio M, Barquinero JF, Vallerga MB, Radl A, Taja MR, Seoane A, De
Luca J, Stuck Oliveira M, Valdivia P, Garcıa Lima O, et al. 2011.
Biological dosimetry intercomparison exercise: an evaluation of triage
and routine mode results by robust methods. Radiat Res. 175:638–649.
Discher M, Woda C, 2013. Thermoluminescence of glass display from
mobile phones for retrospective and accident dosimetry. Radiat
Measure. 53–54:12–21.
Discher M, Woda C, Fiedler I. 2013. Improvement of dose determination
using glass display of mobile phones for accident dosimetry. Radiat
Measure. 56:240–243.
Druzhinin V, Bakanova M, Fucic A, Golovina T, Savchenko Y, Sinitsky M,
Volobaev V. 2016. Lymphocytes with multiple chromosomal damages
in a large cohort of West Siberia residents: results of long-term moni-
toring. Mutat Res. 784–785:1–7.
Gregoire E, Kulka U, Barrios L, Ainsbury E, Bassinet C, Fattibene P,
Oestreicher U, Pantelias G, Terzoudi G, Trompier F, et al. 2016. The har-
monization process to set up and maintain an operational biological
and physical retrospective dosimetry network: QA QM applied to the
RENEB network. Int J Radiat Biol., this issue.
Gruel G, Gregoire E, Lecas S, Martin C, Roch-Lefevre S, Vaurijoux A,
Voisin P, Voisin P, Barquinero JF. 2013. Biological dosimetry by auto-
mated dicentric scoring in a simulated emergency. Radiat Res.
179:557–569.
International Atomic Energy Agency (IAEA). 2011. Cytogenetic dosimetry:
applications in preparedness for and response to radiation emergen-
cies. Vienna: IAEA EPR-Biodosimetry Series. Available at: http://www-
pub.iaea.org/MTCD/publications/PDF/EPR-Biodosimetry%202011_web.
pdf [Accessed 15 March 2016].
International Organization for Standardization (ISO) 13528:2005: Statistical
Methods for use in Proficiency testing by interlaboratory comparisons.
2005. Geneva: ISO.
Kuhn M. 2008. Building predictive models in R using the caret package. J
Statistical Software 28:5. Available at: https://www.jstatsoft.org/article/
view/v028i05/v28i05.pdf [Accessed 29 March 2016].
Kulka U, Abend M, Ainsbury E, Badie C, Barquinero JF, Barrios L, Beinke C,
Bortolin E, Cucu A, De Amicis A, et al. 2016. RENEB – Running the
European Network of biological dosimetry and physical retrospective
dosimetry. Int J Radiat Biol., this issue.
Kulka U, Ainsbury L, Atkinson M, Barnard S, Smith R, Barquinero JF,
Barrios L, Bassinet C, Beinke C, Cucu A, et al. 2015. Realising the
European network of biodosimetry: RENEB – status quo. Radiat Prot
Dosim. 164(1–2):42–45.
Maguire A, Vegacarrascal I, White L, McClean B, Howe O, Lyng FM, Meade
AD. 2015. Analyses of ionizing radiation effects in vitro in peripheral
blood lymphocytes with Raman spectroscopy. Radiat Res. 183:407–416.
Maznyk NA, Wilkins RC, Carr Z, Lloyd DC. 2012. The capacity, capabilities
and needs of the WHO BioDoseNet member laboratories. Radiat Prot
Dosim. 151:611–620.
Manning G, Macaeva E, Majewski M, Kriehuber R, Brzoska K, Abend M,
Doucha-Senf D, Oskamp D, Strunz S, Quintens R, et al. 2016. Comparable
dose estimates of blinded whole blood samples are obtained independ-
ently of culture conditions and analytical approaches – second RENEB
gene expression study. Int J Radiat Biol., this issue.
Meade AD, Howe O, Unterreiner V, Sockalingum GD, Byrne HJ, Lyng FM.
2016. Vibrational spectroscopy in sensing radiobiological effects: analy-
ses of targeted and non-targeted effects in human keratinocytes.
Faraday Discuss. 187:213–234.
Meade AD, Clarke C, Byrne HJ, Lyng FM. 2010. Fourier Transform Infrared
microspectroscopy and multivariate methods for biological dosimetry.
Radiat Res. 173:225–237.
M’kacher R, Andreoletti L, Flamant S, Milliat F, Girinsky T, Dossou J,
Violot D, Assaf E, Clausse B, Koscielny S, et al. 2010. JC human polyo-
mavirus is associated to chromosomal instability in peripheral blood
lymphocytes of Hodgkin’s lymphoma patients and poor clinical out-
come. Ann Oncol. 21:826–832.
M’kacher R, Maalouf EE, Ricoul M, Heidingsfelder L, Laplagne E, Cuceu C,
Hempel WM, Colicchio B, Dieterlen A, Sabatier L. 2014. New tool for
biological dosimetry: reevaluation and automation of the gold stand-
ard method following telomere and centromere staining. Mutat Res.
770:45–53.
M’kacher R, El Maalouf EE, Terzoudi G, Ricoul M, Heidingsfelder L,
Karachristou I, Laplagne E, Hempel WM, Colicchio B, Dieterlen A, et al.
2015. Detection and automated scoring of dicentric chromosomes in non-
stimulated lymphocyte prematurely condensed chromosomes after telo-
mere and centromere staining. Int J Radiat Oncol Biol Phys. 91:640–649.
Oestreicher U, Samaga D, Ainsbury E, Antunes AC, Baeyens A, Barrios L,
Beinke C, Beukes P, Blakely WF, Cucu A, et al. 2016. RENEB
10 E. AINSBURY ET AL.
intercomparisons applying the conventional Dicentric Chromosome
Assay (DCA). Int J Radiat Biol., this issue.
Romm H, Ainsbury E, Barnard S, Barrios L, Barquinero JF, Beinke C, Deperas M,
Gregoire E, Koivistoinen A, Lindholm C, et al. 2014. Validation of semi-auto-
matic scoring of dicentric chromosomes after simulation of three different
irradiation scenarios. Health Phys. 2014;106:764–771.
Romm H, Ainsbury E, Barnard S, Barrios L, Barquinero JF, Beinke C,
Deperas M, Gregoire E, Koivistoinen A, Lindholm C, et al. 2013.
Automatic scoring of dicentric chromosomes as a tool in large scale
radiation accidents. Mutat Res. 756:174–183.
Rozgaj R, Kasuba V, Simic´ D. 2002. The frequency of dicentrics and acen-
trics and the incidence of rogue cells in radiation workers.
Mutagenesis. 17:135–139.
R€uhm W, Fantuzzi E, Harrison R, Schuhmacher H, Vanhavere F, Alves J,
Bottollier Depois JF, Fattibene P, Knezevic´ Z, Lopez MA, et al.. 2016.
EURADOS strategic research agenda: vision for dosimetry of ionising
radiation. Radiat Prot Dosim. 168:223–234.
Trompier F, Burbidge C, Bassinet C, Baumann M, Bortolin E, De Angelis C,
Eakins J, Della Monaca S, Fattibene P, Quattrini MC, et al. 2016.
Overview of physical dosimetry methods for triage application inte-
grated in the new European network RENEB. Int J Radiat Biol., this
issue.
Vaurijoux A, Gruel G, Pouzoulet F, Gregoire E, Martin C, Roch-Lefe?vre S,
Voisin P, Voisin P, Roy L. 2009. Strategy for population triage based on
dicentric analysis. Radiat Res. 171:541–548.
Vaurijoux A, Gruel G, Gregoire E, Sandrine Roch-Lefevre, Voisin P,
Martin C, Voisin P, Roy L, Barquinero JF. 2015. Automatic dicentric scor-
ing a real option to be used in biological dosimetry. Radiat Emerg
Med. 4:16–21.
Wilkins RC, Beaton-Green LA, Lachapelle S, Kutzner BC, Ferrarotto C,
Chauhan V, Marro L, Livingston GK, Boulay Greene H, Flegal FN. 2015.
Evaluation of the annual Canadian biodosimetry network intercompari-
sons. Int J Radiat Biol. 91:443–451.
Woda C, Bassinet C, Discher M, Della Monaca S, Bortolin E,
Fattibene P, Quattrini MC, Sholom S, McKeever SWS, Cemusova
Z, et al. A joint EURADOS and RENEB TL inter-comparison of dis-
play glass from mobile phones for retrospective dosimetry. In
preparation.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY 11
